129 related articles for article (PubMed ID: 9530982)
21. Percutaneous absorption of acemetacin from a membrane controlled transdermal system and prediction of the disposition of the drug in rats.
Ito Y; Ogiso T; Iwaki M; Tanino T; Terao M
Biol Pharm Bull; 1993 Jun; 16(6):583-8. PubMed ID: 8364511
[TBL] [Abstract][Full Text] [Related]
22. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems.
Sintov AC; Botner S
Int J Pharm; 2006 Mar; 311(1-2):55-62. PubMed ID: 16431047
[TBL] [Abstract][Full Text] [Related]
23. Alpha-monoisostearyl glyceryl ether enhances percutaneous penetration of indometacin in-vivo.
Suzuki A; Yamaguchi T; Kawasaki K; Hase T; Tokimitsu I
J Pharm Pharmacol; 2002 Dec; 54(12):1601-7. PubMed ID: 12542888
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of formulated tenoxicam transdermal delivery systems.
Kim T; Kang E; Chun I; Gwak H
J Pharm Pharmacol; 2008 Jan; 60(1):135-8. PubMed ID: 18088513
[TBL] [Abstract][Full Text] [Related]
25. Drug targeting efficacy to underlying muscle following topical application. I. Evaluation based on a physiological pharmacokinetic model.
Hatanaka T; Manabe E; Ohtsuki T; Okuyama K; Mori M; Okada H; Katayama K; Koizumi T
Biol Pharm Bull; 2000 Jul; 23(7):860-5. PubMed ID: 10919367
[TBL] [Abstract][Full Text] [Related]
26. Bioavailability of indomethacin in liposomes.
Stozek T
Acta Pol Pharm; 1992; 49(4):21-6. PubMed ID: 16092430
[TBL] [Abstract][Full Text] [Related]
27. Ocular pharmacokinetics profile of different indomethacin topical formulations.
Bucolo C; Melilli B; Piazza C; Zurria M; Drago F
J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858
[TBL] [Abstract][Full Text] [Related]
28. Pharmacodynamic and pharmacokinetic evaluation of lipid microspheres of indomethacin.
Srinath P; Diwan PV
Pharm Acta Helv; 1998 Dec; 73(4):199-203. PubMed ID: 9861868
[TBL] [Abstract][Full Text] [Related]
29. External control of drug release and penetration: enhancement of the transdermal absorption of indomethacin by ultrasound irradiation.
Miyazaki S; Mizuoka H; Oda M; Takada M
J Pharm Pharmacol; 1991 Feb; 43(2):115-6. PubMed ID: 1672894
[TBL] [Abstract][Full Text] [Related]
30. External control of drug release and penetration. VI. Enhancing effect of ultrasound on the transdermal absorption of indomethacin from an ointment in rats.
Miyazaki S; Mizuoka H; Kohata Y; Takada M
Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2826-30. PubMed ID: 1464116
[TBL] [Abstract][Full Text] [Related]
31. Topical delivery of leflunomide for rheumatoid arthritis treatment: evaluation of local tissue deposition of teriflunomide and its anti-inflammatory effects in an arthritis rat model.
Bae J; Park JW
Drug Dev Ind Pharm; 2016; 42(2):254-62. PubMed ID: 26006334
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the percutaneous penetration of indomethacin from soybean oil microemulsion: effects of the HLB value of mixed surfactants.
Chen L; Tan F; Wang J; Liu F
Pharmazie; 2012 Jan; 67(1):31-6. PubMed ID: 22393828
[TBL] [Abstract][Full Text] [Related]
33. Investigation of true nanoemulsions for transdermal potential of indomethacin: characterization, rheological characteristics, and ex vivo skin permeation studies.
Shakeel F; Ramadan W; Ahmed MA
J Drug Target; 2009 Jul; 17(6):435-41. PubMed ID: 19527114
[TBL] [Abstract][Full Text] [Related]
34. Assessment of topical non-steroidal anti-inflammatory drugs.
Poelman MC; Piot B; Guyon F; Deroni M; Leveque JL
J Pharm Pharmacol; 1989 Oct; 41(10):720-2. PubMed ID: 2575154
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of matrix type mucoadhesive tablets containing indomethacin for buccal application.
Ikeuchi-Takahashi Y; Sasatsu M; Onishi H
Int J Pharm; 2013 Sep; 453(2):454-61. PubMed ID: 23791737
[TBL] [Abstract][Full Text] [Related]
36. Amphiphilic star-like macromolecules as novel carriers for topical delivery of nonsteroidal anti-inflammatory drugs.
Djordjevic J; Michniak B; Uhrich KE
AAPS PharmSci; 2003 Oct; 5(4):E26. PubMed ID: 15198514
[TBL] [Abstract][Full Text] [Related]
37. Carrier free indomethacin microparticles for dry powder inhalation.
Ceschan NE; Bucalá V; Mateos MV; Smyth HDC; Ramírez-Rigo MV
Int J Pharm; 2018 Oct; 549(1-2):169-178. PubMed ID: 30071308
[TBL] [Abstract][Full Text] [Related]
38. Enhancing effect of alpha-monoisostearyl glyceryl ether on the percutaneous penetration of indomethacin through excised rat skin.
Suzuki A; Yamaguchi T; Kawasaki K; Hase T; Tokimitsu I
Biol Pharm Bull; 2001 Jun; 24(6):698-700. PubMed ID: 11411562
[TBL] [Abstract][Full Text] [Related]
39. [Anti-inflammatory effects and aqueous humor concentration of various nonsteroidal anti-inflammatory drugs in extracapsular cataract surgery].
Hessemer V; Schmitt K; Jacobi A
Klin Monbl Augenheilkd; 1996 Mar; 208(3):161-6. PubMed ID: 8699774
[TBL] [Abstract][Full Text] [Related]
40. The influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAID's on their transdermal absorption.
Beetge E; du Plessis J; Müller DG; Goosen C; van Rensburg FJ
Int J Pharm; 2000 Jan; 193(2):261-4. PubMed ID: 10606790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]